PHARMACOKINETIC PROPERTIES OF A NEW KAPPA-OPIOID ANALGESIC RU-1205 COMPOUND AT A SINGLE PERORAL ADMINISTRATION

Author:

Spasov A. A.1ORCID,Smirnova L. A.2ORCID,Grechko O. Yu.1ORCID,Eliseeva N. V.1ORCID,Lifanova Yu. V.1ORCID,Rashchenko A. I.1ORCID,Zhukovskaya O. N.3ORCID,Morkovnik A. S.3ORCID,Anisimova V. A.3ORCID

Affiliation:

1. Volgograd State Medical University 1, Pavshikh Bortsov Square, Volgograd, Russia 400131

2. 1. Volgograd State Medical University 1, Pavshikh Bortsov Square, Volgograd, Russia 400131 2. Volgograd Medical Research Center; 1, Pavshikh Bortsov Square, Volgograd, Russia, 400131

3. Scientific Research Institute of Physical and Organic Chemistry, Southern Federal University Bldg. 2, 194, Stachki Ave., Rostov-on-Don, Russia, 344090

Abstract

The aim of the study is the investigation of the pharmacokinetic properties of the RU-1205 compound, with previously identified kappa-agonistic and analgesic effects, at a single oral administration, as well as comparison of the relationship between its pharmacokinetic and analgesic properties.Materials and methods. Pharmacokinetic parameters of RU-1205 after the oral administration at the dose of 50 mg / kg were investigated using the method of High Performance Liquid Chromatography  with determination of the concentration of the compound according to the previously constructed calibration schedule. The indices of the area under the pharmacokinetic curve, clearance, half-life, residence time of the drug molecule in the body, a total (apparent) volume of distribution, as well as the indicator of absolute bioavailability, were calculated. The tissue distribution and excretion of RU-1205 were studied.Potential metabolites of RU-1205 were predicted using the PALLAS 3.00 program. The study of the analgesic activity was carried out on a model of central somatogenic pain with electricalstimulation, with the dynamics assessment of the voltage amplitude of the corresponding reaction of the "tail-flick" reflex.Results. The compound under study is rapidly adsorbed from the gastrointestinal tract, reaching a maximum concentration by the end of the first hour of the study, and is determined in plasma within 12 hours. Its half-life is 17.7 hours. The absolute oral bioavailability is 37.3%. It was found out that the compound is withdrawn within 3-4 days. The main route of excretion is extrarenal. Biotransformation of a substance probably proceeds mainly with the formation of oxidized forms of the initial molecule by reactions of the first phase of metabolic transformation. The analgesic effect is long-lasting: it starts after 15 minutes and lasts for 12 hours with flattening of the curve by the 8th hour.Conclusion. When administered orally, the test substance undergoes a long process of elimination, has the greatest tropism for the elimination organs and undergoes active biotransformation processes in the body of animals. As a result of it, active metabolic products with an analgesic activity are, possibly, formed.

Publisher

Volgograd State Medical University

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Pharmacy

Reference45 articles.

1. Harbaugh CM, Suwanabol PA. Optimizing Pain Control During the Opioid Epidemic. Surg Clin North Am. 2019 Oct;99(5):867-883. DOI: 10.1016/j.suc.2019.06.002.

2. Arbuck DM, Abuzarova GR, Alekseeva GS. Opioids in pain syndrome management (part 1). Messenger of Anesthesiology and Resuscitation. 2017;14(3):58-67. DOI: 10.21292/2078-5658-2017-14-3-58-67. Russian

3. Wang S. Historical Review: Opiate Addiction and Opioid Receptors. Cell Transplant. 2019 Mar;28(3):233-238. DOI: 10.1177/0963689718811060.

4. Palekhov AV, Vvedenskaya ES. The problems of opioid analgesics provision. The subservice part of the iceberg. Kachestvennaya Klinicheskaya Praktika [Good Clinical Practice]. 2017;(2):43-48. Russian

5. FDA (Food and Drug Administrtion). Analysis of Long-Term Trends in Prescription Opioid Analgesic Products: Quantity, Sales, and Price Trends.FDA Report. 2018: 1–12.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Effects of a New Kappa Agonist (Fluorophenyl Derivative of Imidazo[1,2-<i>а</i>]benzimidazole) on the Rat Genome;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2023-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3